KCNN4 and pulmonary fibrosis: Recently, the intermediate-conductance Ca2+-activated K+ channel (KCa3.1) has been proposed as the “switch” molecule of fibrotic disease because it regulates the proliferation, migration, and differentiation of renal and pulmonary fibrosis-producing cells [95–97].